| Code | Description | Claims | Beneficiaries | Total Paid |
| 36415 |
Collection of venous blood by venipuncture |
24,070 |
16,741 |
$886K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,162 |
12,786 |
$829K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,238 |
13,382 |
$819K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,979 |
7,334 |
$383K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,266 |
2,602 |
$259K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,567 |
4,559 |
$237K |
| 80053 |
Comprehensive metabolic panel |
20,017 |
15,765 |
$232K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,921 |
1,613 |
$222K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,726 |
1,405 |
$170K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,672 |
2,360 |
$140K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,783 |
1,592 |
$119K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,535 |
1,339 |
$105K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,113 |
898 |
$80K |
| 71045 |
Radiologic examination, chest; single view |
8,960 |
7,312 |
$73K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
422 |
326 |
$68K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,744 |
1,421 |
$65K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
650 |
549 |
$58K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,343 |
2,739 |
$54K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
603 |
493 |
$53K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
877 |
707 |
$41K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
261 |
239 |
$38K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,979 |
3,306 |
$37K |
| 71046 |
Radiologic examination, chest; 2 views |
1,884 |
1,606 |
$36K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
814 |
213 |
$35K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,838 |
1,461 |
$33K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
736 |
540 |
$33K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,579 |
3,733 |
$32K |
| 81001 |
|
8,055 |
6,684 |
$32K |
| 76641 |
|
658 |
565 |
$31K |
| 81003 |
|
5,255 |
4,369 |
$27K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,686 |
16,637 |
$27K |
| G0378 |
Hospital observation service, per hour |
2,998 |
1,416 |
$25K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,082 |
6,885 |
$24K |
| 81025 |
|
4,664 |
4,000 |
$24K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,718 |
2,013 |
$24K |
| 73610 |
|
593 |
512 |
$24K |
| 82947 |
|
2,535 |
1,259 |
$23K |
| 59025 |
Fetal non-stress test |
464 |
314 |
$23K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,277 |
1,195 |
$22K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,978 |
2,149 |
$21K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
303 |
119 |
$21K |
| 85610 |
|
5,568 |
4,160 |
$20K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,117 |
1,742 |
$20K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,207 |
2,738 |
$20K |
| 93975 |
|
1,057 |
922 |
$19K |
| 73630 |
|
729 |
633 |
$19K |
| 73562 |
|
684 |
555 |
$18K |
| 73030 |
|
470 |
371 |
$18K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,452 |
1,185 |
$17K |
| 73130 |
|
443 |
386 |
$17K |
| 87081 |
|
594 |
537 |
$17K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,893 |
5,596 |
$16K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
380 |
294 |
$15K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,999 |
890 |
$15K |
| 82962 |
|
1,810 |
755 |
$15K |
| 00731 |
|
264 |
223 |
$14K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,148 |
1,031 |
$14K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,127 |
3,332 |
$13K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
861 |
748 |
$13K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
972 |
847 |
$12K |
| 85730 |
|
4,030 |
3,069 |
$12K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
210 |
191 |
$12K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
473 |
421 |
$12K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
526 |
477 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,078 |
1,158 |
$11K |
| C1769 |
Guide wire |
654 |
470 |
$11K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
934 |
881 |
$11K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,570 |
4,684 |
$11K |
| 84484 |
|
6,326 |
3,491 |
$10K |
| 86850 |
|
1,351 |
1,059 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
165 |
134 |
$9K |
| 93017 |
|
466 |
365 |
$8K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
363 |
303 |
$8K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
212 |
189 |
$8K |
| 80050 |
General health panel |
922 |
827 |
$8K |
| 73110 |
|
171 |
144 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,519 |
3,584 |
$8K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,818 |
1,394 |
$7K |
| 87631 |
|
194 |
171 |
$7K |
| 83735 |
|
4,079 |
3,051 |
$6K |
| J2704 |
Injection, propofol, 10 mg |
3,991 |
3,099 |
$6K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,585 |
912 |
$6K |
| 71250 |
|
117 |
96 |
$6K |
| 85027 |
|
1,716 |
1,331 |
$6K |
| 76830 |
Ultrasound, transvaginal |
174 |
155 |
$6K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,902 |
1,930 |
$6K |
| 76801 |
|
642 |
531 |
$5K |
| 72100 |
|
288 |
235 |
$5K |
| 83690 |
|
3,957 |
3,233 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
292 |
246 |
$5K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,917 |
1,275 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,653 |
3,747 |
$4K |
| 77066 |
Tomosynthesis, mammo |
45 |
39 |
$4K |
| 99153 |
Mod sedat endo service >5yrs |
207 |
162 |
$4K |
| 99152 |
|
119 |
92 |
$4K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
894 |
695 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,949 |
3,936 |
$4K |
| 86900 |
|
2,012 |
1,595 |
$4K |
| 96376 |
|
209 |
163 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,557 |
2,074 |
$4K |
| 00811 |
|
28 |
25 |
$4K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
819 |
644 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
543 |
488 |
$3K |
| 87040 |
|
1,999 |
1,064 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,934 |
1,527 |
$3K |
| 74018 |
|
163 |
140 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,691 |
2,227 |
$3K |
| 83880 |
|
1,488 |
1,143 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
797 |
709 |
$3K |
| 80061 |
Lipid panel |
3,625 |
3,010 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,520 |
2,080 |
$2K |
| 87210 |
|
268 |
228 |
$2K |
| 83605 |
|
1,739 |
1,329 |
$2K |
| 93971 |
|
111 |
95 |
$2K |
| 87186 |
|
1,498 |
1,244 |
$2K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
350 |
256 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,438 |
1,192 |
$2K |
| 84703 |
|
2,364 |
2,052 |
$2K |
| 97161 |
|
103 |
81 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
116 |
92 |
$2K |
| 72131 |
|
99 |
78 |
$2K |
| 87070 |
|
359 |
286 |
$2K |
| 73502 |
|
80 |
63 |
$2K |
| 82607 |
|
1,057 |
862 |
$1K |
| 97597 |
|
21 |
12 |
$1K |
| 86901 |
|
2,020 |
1,602 |
$1K |
| 84702 |
|
1,353 |
1,060 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
545 |
491 |
$1K |
| 87807 |
|
230 |
210 |
$995.58 |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
46 |
38 |
$991.48 |
| 73080 |
|
34 |
28 |
$987.13 |
| 84600 |
|
858 |
683 |
$921.99 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
17 |
12 |
$905.92 |
| 92551 |
|
21 |
19 |
$866.70 |
| 85379 |
|
1,078 |
914 |
$834.58 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
844 |
742 |
$761.20 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,094 |
851 |
$741.33 |
| 87088 |
|
902 |
764 |
$683.19 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
13 |
12 |
$675.90 |
| 87077 |
|
152 |
123 |
$607.88 |
| 82746 |
|
272 |
224 |
$601.10 |
| 88342 |
|
761 |
639 |
$544.41 |
| 82570 |
|
733 |
504 |
$528.76 |
| 82550 |
|
237 |
178 |
$504.13 |
| 85378 |
|
19 |
15 |
$452.92 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
485 |
396 |
$421.33 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
28 |
25 |
$402.07 |
| 84439 |
|
969 |
794 |
$375.95 |
| J3490 |
Unclassified drugs |
19 |
13 |
$266.45 |
| 82553 |
|
42 |
31 |
$251.10 |
| 86140 |
|
374 |
298 |
$177.09 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
551 |
421 |
$152.76 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
110 |
97 |
$140.93 |
| 80143 |
|
399 |
355 |
$135.39 |
| 90715 |
|
80 |
64 |
$133.04 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
99 |
75 |
$132.86 |
| 88313 |
|
311 |
266 |
$124.44 |
| 80179 |
|
302 |
264 |
$90.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
283 |
233 |
$88.05 |
| J2060 |
Injection, lorazepam, 2 mg |
336 |
253 |
$86.94 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
60 |
42 |
$73.93 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
97 |
69 |
$73.93 |
| 82043 |
|
298 |
240 |
$66.98 |
| 87205 |
|
343 |
272 |
$57.52 |
| 82728 |
|
221 |
175 |
$54.01 |
| 87428 |
|
150 |
147 |
$30.81 |
| A4218 |
Sterile saline or water, metered dose dispenser, 10 ml |
73 |
62 |
$27.51 |
| 88307 |
|
32 |
25 |
$24.80 |
| 82805 |
|
51 |
38 |
$19.49 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
89 |
71 |
$19.06 |
| 80069 |
|
29 |
13 |
$17.13 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
45 |
30 |
$13.30 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
142 |
128 |
$10.76 |
| 83540 |
|
163 |
123 |
$7.38 |
| 83550 |
|
129 |
103 |
$6.68 |
| 80320 |
|
18 |
14 |
$6.68 |
| 85014 |
|
64 |
56 |
$4.11 |
| 87075 |
|
16 |
12 |
$2.69 |
| 85520 |
|
18 |
13 |
$2.38 |
| 85018 |
|
64 |
55 |
$2.05 |
| 85651 |
|
183 |
150 |
$2.05 |
| 84156 |
|
14 |
12 |
$1.48 |
| J7510 |
Prednisolone oral, per 5 mg |
77 |
67 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
220 |
115 |
$0.00 |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
283 |
212 |
$0.00 |
| 00840 |
|
48 |
37 |
$0.00 |
| 84550 |
|
109 |
80 |
$0.00 |
| 36600 |
|
29 |
27 |
$0.00 |
| 00812 |
|
16 |
14 |
$0.00 |
| 83970 |
|
17 |
13 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
22 |
12 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
85 |
73 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
59 |
40 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
83 |
76 |
$0.00 |
| 86403 |
|
28 |
27 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
54 |
43 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
17 |
14 |
$0.00 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
16 |
15 |
$0.00 |